Phospholipase A2 Inhibitors
- Name
- Phospholipase A2 Inhibitors
- Accession Number
- DBCAT001741
- Description
Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme.
- Drugs
Drug Drug Description Varespladib methyl Investigated for use/treatment in atherosclerosis and coronary artery disease. Darapladib Investigated for use/treatment in atherosclerosis. Varespladib Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome. - Drugs & Drug Targets
Drug Target Type Varespladib methyl Phospholipase A2, membrane associated target Varespladib methyl Group 10 secretory phospholipase A2 target Darapladib Cytosolic phospholipase A2 target